InvestorsHub Logo
Followers 11
Posts 292
Boards Moderated 0
Alias Born 03/11/2011

Re: None

Friday, 09/23/2016 10:00:50 AM

Friday, September 23, 2016 10:00:50 AM

Post# of 48316
It will soon look to start testing new highs, maybe from $1.93-$1.97, and in October the Phase1 study for Evaluation of Pharmacodynamic effects of IT-pIL12-EP in patients with TNBC concludes. Dr. Melinda Telli might be speaking on the subject on Nov.4, when she will be giving an update in Triple Negative Breast Cancer.
http://bcconnections.org/events/conference/